NO2882743T3 - - Google Patents

Info

Publication number
NO2882743T3
NO2882743T3 NO13742640A NO13742640A NO2882743T3 NO 2882743 T3 NO2882743 T3 NO 2882743T3 NO 13742640 A NO13742640 A NO 13742640A NO 13742640 A NO13742640 A NO 13742640A NO 2882743 T3 NO2882743 T3 NO 2882743T3
Authority
NO
Norway
Application number
NO13742640A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2882743T3 publication Critical patent/NO2882743T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/396—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO13742640A 2012-07-30 2013-07-30 NO2882743T3 (OSRAM)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1213486.2A GB201213486D0 (en) 2012-07-30 2012-07-30 Quinone compounds and their uses for the treatment of cancer
PCT/EP2013/065968 WO2014020012A1 (en) 2012-07-30 2013-07-30 Quinone compounds and their uses for the treatment of cancer

Publications (1)

Publication Number Publication Date
NO2882743T3 true NO2882743T3 (OSRAM) 2018-05-12

Family

ID=46881339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13742640A NO2882743T3 (OSRAM) 2012-07-30 2013-07-30

Country Status (16)

Country Link
US (1) US9266829B2 (OSRAM)
EP (1) EP2882743B1 (OSRAM)
JP (1) JP6317742B2 (OSRAM)
KR (1) KR102142164B1 (OSRAM)
CN (1) CN104583200B (OSRAM)
AU (1) AU2013298653B2 (OSRAM)
BR (1) BR112015001837B1 (OSRAM)
CA (1) CA2880021C (OSRAM)
DK (1) DK2882743T3 (OSRAM)
ES (1) ES2662917T3 (OSRAM)
GB (2) GB201213486D0 (OSRAM)
IN (1) IN2015DN01223A (OSRAM)
MX (1) MX361650B (OSRAM)
NO (1) NO2882743T3 (OSRAM)
RU (1) RU2688675C2 (OSRAM)
WO (1) WO2014020012A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115887684B (zh) * 2022-12-02 2025-02-14 南京邮电大学 基于dna折纸和阿霉素前药构筑的递药纳米体系及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156744A (en) * 1998-03-19 2000-12-05 Cancer Research Campaign Tech (London) DT-diaphorase directed anti-tumor agents
KR20070032795A (ko) * 2004-06-21 2007-03-22 허치슨 메디파르마 엔터프라이즈 리미티드 항암 화학요법
CN101677942B (zh) * 2007-03-13 2013-10-30 光谱医药公司 阿帕兹醌在制造切除膀胱肿瘤后治疗膀胱癌的药物的用途

Also Published As

Publication number Publication date
ES2662917T3 (es) 2018-04-10
RU2688675C2 (ru) 2019-05-22
AU2013298653A1 (en) 2015-02-19
DK2882743T3 (en) 2018-03-12
RU2015105036A (ru) 2016-09-20
CN104583200A (zh) 2015-04-29
MX361650B (es) 2018-12-13
MX2015000969A (es) 2015-09-23
WO2014020012A1 (en) 2014-02-06
GB2519004A (en) 2015-04-08
JP2015524815A (ja) 2015-08-27
BR112015001837B1 (pt) 2021-11-16
EP2882743A1 (en) 2015-06-17
CA2880021C (en) 2020-01-14
AU2013298653B2 (en) 2017-10-19
US9266829B2 (en) 2016-02-23
BR112015001837A2 (pt) 2017-07-04
GB201213486D0 (en) 2012-09-12
KR102142164B1 (ko) 2020-08-06
JP6317742B2 (ja) 2018-04-25
EP2882743B1 (en) 2017-12-13
GB2519004B (en) 2016-03-30
IN2015DN01223A (OSRAM) 2015-06-26
HK1209111A1 (zh) 2016-03-24
CA2880021A1 (en) 2014-02-06
US20150210639A1 (en) 2015-07-30
KR20150036215A (ko) 2015-04-07
CN104583200B (zh) 2017-07-25

Similar Documents

Publication Publication Date Title
BR112014024762A2 (OSRAM)
BR112014018801A2 (OSRAM)
BR112014017625A2 (OSRAM)
BR112014017659A2 (OSRAM)
BR112014017607A2 (OSRAM)
BR112014017646A2 (OSRAM)
BR112014017638A2 (OSRAM)
BR112014019038A2 (OSRAM)
AR092201A1 (OSRAM)
BR112013027865A2 (OSRAM)
BR112014017609A2 (OSRAM)
BR112014017644A2 (OSRAM)
BR112014017634A2 (OSRAM)
BR112014018187A2 (OSRAM)
BR112014017588A2 (OSRAM)
BR112014017647A2 (OSRAM)
BR112014013184A8 (OSRAM)
BR112014017618A2 (OSRAM)
BR112014017627A2 (OSRAM)
BR112014017623A2 (OSRAM)
BR112014017652A2 (OSRAM)
BR112014017630A2 (OSRAM)
BR112014017621A2 (OSRAM)
BR112014017631A2 (OSRAM)
BR112014017671A2 (OSRAM)